PYREXIA is the #8 most commonly reported adverse reaction for GEMCITABINE HYDROCHLORIDE, manufactured by Armas Pharmaceuticals Inc.. There are 2,528 FDA adverse event reports linking GEMCITABINE HYDROCHLORIDE to PYREXIA. This represents approximately 2.7% of all 92,220 adverse event reports for this drug.
Patients taking GEMCITABINE HYDROCHLORIDE who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
PYREXIA2,528 of 92,220 reports
PYREXIA is a less commonly reported adverse event for GEMCITABINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
Other Side Effects of GEMCITABINE HYDROCHLORIDE
In addition to pyrexia, the following adverse reactions have been reported for GEMCITABINE HYDROCHLORIDE:
PYREXIA has been reported as an adverse event in 2,528 FDA reports for GEMCITABINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is PYREXIA with GEMCITABINE HYDROCHLORIDE?
PYREXIA accounts for approximately 2.7% of all adverse event reports for GEMCITABINE HYDROCHLORIDE, making it a notable side effect.
What should I do if I experience PYREXIA while taking GEMCITABINE HYDROCHLORIDE?
If you experience pyrexia while taking GEMCITABINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.